\-\ Texto\\:\\ \ \(0\)\
\-\ nasal\\ mass\\ visible\\ on\\ right\\.\ \(0\)\
\-\ surgical\\ resection\\ followed\\ by\\ chemotherapy\ \(0\)\
\-\ enhancing\\ right\\-sided\\ nasal\\ mass\\ eroding\\ into\\ the\\ cribiform\\ fossa\\.\\ \\ there\\ are\\ associated\\ changes\\ of\\ both\\ acute\\ and\\ chronic\\ sinusitis\\.\ \(0\)\
\-\ esthesioneuroblastoma\ \(3\)\
\-\ \\â\\€\\¢\\ nasal\\ polyps\ \(0\)\
\-\ \\â\\€\\¢\\ squamous\\ cell\\ carcinoma\ \(1\)\
\-\ \\â\\€\\¢\\ inverting\\ papilloma\ \(1\)\
\-\ \\â\\€\\¢\\ esthesioneurblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ neuroendocrine\\ tumor\ \(0\)\
\-\ 38\\ year\\ old\\ woman\\ with\\ 1\\ to\\ 2\\ year\\ history\\ of\\ intermittent\\ epistaxis\\.\\ \\ this\\ evaluation\\ is\\ for\\ symptoms\\ of\\ nasal\\ obstruction\\ and\\ imaging\\ was\\ done\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasal\\:\\ 0\\.22562938374911606\ \(0\)\
\-\ esthesioneurblastoma\\:\\ 0\\.11754024565288665\ \(0\)\
\-\ esthesioneuroblastoma\\:\\ 0\\.1082982832454207\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.10446762343972586\ \(0\)\
\-\ cribiform\\:\\ 0\\.09365011939651258\ \(0\)\
\-\ eroding\\:\\ 0\\.09159477699881581\ \(0\)\
\-\ inverting\\:\\ 0\\.08824391795507039\ \(0\)\
\-\ neuroendocrine\\:\\ 0\\.0868391110796327\ \(0\)\
\-\ epistaxis\\:\\ 0\\.08235281459134987\ \(0\)\
\-\ polyps\\:\\ 0\\.06903909685653484\ \(0\)\
\-\ sinusitis\\:\\ 0\\.06592423217411478\ \(0\)\
\-\ 38\\:\\ 0\\.06070451395900244\ \(0\)\
\-\ papilloma\\:\\ 0\\.05724973129223278\ \(0\)\
\-\ squamous\\:\\ 0\\.05574385914315817\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.05561503366433501\ \(0\)\
\-\ visible\\:\\ 0\\.05393111732667778\ \(0\)\
\-\ intermittent\\:\\ 0\\.04890698596204061\ \(0\)\
\-\ done\\:\\ 0\\.04723358487203669\ \(0\)\
\-\ fossa\\:\\ 0\\.04643732840934839\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04083927713521154\ \(0\)\
\-\ obstruction\\:\\ 0\\.04017866731452581\ \(0\)\
\-\ followed\\:\\ 0\\.03819834495171696\ \(0\)\
\-\ enhancing\\:\\ 0\\.03573271377179679\ \(0\)\
\-\ resection\\:\\ 0\\.035532208740269584\ \(0\)\
\-\ evaluation\\:\\ 0\\.03309651727769077\ \(0\)\
\-\ changes\\:\\ 0\\.032653973016467476\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03229236893354489\ \(0\)\
\-\ chronic\\:\\ 0\\.032093195105426665\ \(0\)\
\-\ mass\\:\\ 0\\.03169229351860172\ \(0\)\
\-\ cell\\:\\ 0\\.030776542821086484\ \(0\)\
\-\ both\\:\\ 0\\.029095999875814953\ \(0\)\
\-\ symptoms\\:\\ 0\\.028395433025308524\ \(0\)\
\-\ acute\\:\\ 0\\.028131724388086605\ \(0\)\
\-\ into\\:\\ 0\\.02711101823946276\ \(0\)\
\-\ 1\\:\\ 0\\.02711101823946276\ \(0\)\
\-\ associated\\:\\ 0\\.026886167492102694\ \(0\)\
\-\ imaging\\:\\ 0\\.026694317659408037\ \(0\)\
\-\ tumor\\:\\ 0\\.026563097354810817\ \(0\)\
\-\ woman\\:\\ 0\\.02631870596651875\ \(0\)\
\-\ year\\:\\ 0\\.025496140513944394\ \(0\)\
\-\ 2\\:\\ 0\\.02453472662014062\ \(0\)\
\-\ surgical\\:\\ 0\\.023949623603352715\ \(0\)\
\-\ by\\:\\ 0\\.018971612043264998\ \(0\)\
\-\ there\\:\\ 0\\.016956207419533183\ \(0\)\
\-\ history\\:\\ 0\\.015736193836094446\ \(0\)\
\-\ are\\:\\ 0\\.015531651633728024\ \(0\)\
\-\ was\\:\\ 0\\.013177033629515824\ \(0\)\
\-\ this\\:\\ 0\\.012815162844188441\ \(0\)\
\-\ right\\:\\ 0\\.012021756121472223\ \(0\)\
\-\ old\\:\\ 0\\.011665794624830063\ \(0\)\
\-\ for\\:\\ 0\\.009721441981902869\ \(0\)\
\-\ on\\:\\ 0\\.009651880164872374\ \(0\)\
\-\ is\\:\\ 0\\.007497210378463009\ \(0\)\
\-\ to\\:\\ 0\\.005694241445906484\ \(0\)\
\-\ and\\:\\ 0\\.004800240152859159\ \(0\)\
\-\ of\\:\\ 0\\.004660152031919537\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
\-\ the\\:\\ 0\\.001843323796048344\ \(0\)\
\-\ with\\:\\ 0\\.00156005568119853\ \(0\)\
